Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02447406
Brief Title: Phase Ib, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel, in Any Solid Cancer and Sequential Phase II, Single-arm Study of AZD6094 (Volitinib) in Combination With Docetaxel in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Second Line Treatment

First Submitted : May 14, 2015
First Submitted that Met QC Criteria : May 15, 2015
First Posted : May 18, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : February 15, 2017
Last Update Posted : February 16, 2017